Ladies and gentlemen, thank you for standing by, and welcome to Ceragon Networks Conference Call. [Operator Instructions] I must advise you that this call is being recorded. I'd now like to hand it over to Rob Fink, Head of Investor Relations. Please go ahead, sir.

Thank you, operator, and good morning, everyone. Hosting today's call is Doron Arazi, Ceragon's Chief Executive Officer and Ronen Stein, Chief Financial Officer. Before we start, I'd like to note that certain statements made on this call including projected financial information, results and the company's future initiatives, future events, business outlook, development efforts and their potential outcome, anticipated progress and plans, results and timelines and other financial accounting related matters constitute forward-looking statements within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended, and the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Ceragon intends forward-looking terminology, such as believes, expects, may, will, should, anticipates, plans or similar expressions to identify forward-looking statements. Such statements reflect only current beliefs, expectations and assumptions of Ceragon's management. Actual results, performance or achievements of Ceragon may differ materially, as they are subject to certain risks and uncertainties, which could cause Ceragon's actual results to differ materially from those projected in such forward-looking statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties that are described in Ceragon's most recent Annual Report on Form 20-F and may be supplemented from time to time in Ceragon's other filings with the SEC, including today's earlier filing. The earnings PR, all of which are expressly incorporated herein by reference. Forward-looking statements related to the date initially made do not purport to be predictions of future events or results and there could be no assurances that they will prove to be accurate, and Ceragon undertakes no obligation to update them. Ceragon's public filings are available on the Securities and Exchange Commission's website at sec.gov, and may also be obtained from Ceragon's website at ceragon.com. Also, today's call will include non-GAAP numbers. For a reconciliation between GAAP and non-GAAP results, please see the tables attached to the press release that was issued earlier today, which is posted on the Investor Relations section of Ceragon's website. With all that said, I would now like to turn the call over to Doron. Doron, please go ahead.

Thank you, Rob, and good morning, everyone. This was a solid start to 2024 for Ceragon. We are executing against our strategic plan and are on pace to achieve our full year growth and profitability targets. Demand for our solutions is strong and growing in North America and India in particular, and we are expanding our presence with private network customers globally. We grew revenue year-over-year, expanded our gross profit margins and delivered another profitable quarter with positive free cash flow. The quarter was highlighted by a particularly strong booking level. The large-scale network modernization project for a Tier 1 operator in India was a major contributor to the higher bookings, as we received significant initial orders against the agreement. We continue to generate strong bookings in North America as well and we generated improved bookings in all other regions sequentially. The strong bookings give us visibility and optimism that we will achieve our full year growth and profitability targets. Our new products and solutions are serving as a catalyst for our business. As expected, our new offerings are creating higher customer interest and are starting to translate the bookings and revenue. We used Mobile World Congress as a venue to showcase our next generation solutions. We also started delivering significant quantities of one of our new products in the first quarter. Some of the new solutions in our portfolio that are worth highlighting, include: first, our multihaul or fixed wireless access family of point to multi-point solutions that operate in the V-band frequency, opening doors to diverse applications through its use of unlicensed spectrum along with its high capacity and short range characteristics. These quantities are ideal for both private networks and service providers aiming to establish swift connections in confined, dense areas such as cities and campuses. Next,…

Thank you, Doron, and good morning, everyone. As Doron outlined, the first quarter represented a solid start to the year for Ceragon. To help you understand the results, I will be referring primarily to non-GAAP financials. For more information regarding our use of non-GAAP financial measures, including reconciliations of these measures, we refer to today's press release. Let me now review the actual results. Revenues were $88.5 million, up 6% from $83.4 million in Q1 2023. Our strongest regions in terms of revenues for the quarter were North America and India with $28.9 million and $26 million, respectively, in line with the continuous strong demand we see in these regions. Our third strongest region in terms of revenues was EMEA with $14.9 million. We had 2 customers in the first quarter that contributed more than 10% of our revenues. Gross profit for the first quarter on a non-GAAP basis was $32.5 million, an increase of 14.7% compared to $28.4 million in Q1 2023. Our non-GAAP gross margin was 36.7% compared with gross margin of 34% in Q1 2023. We continue to achieve high gross margins, mainly as North America becomes the strongest region in terms of revenue, with record quarterly revenues and product mix continue to be favorable while we keep costs under control. Our gross margins may continue to fluctuate from quarter-to-quarter due to changes in product and regional mix. As for the operating expenses: In general, this quarter's operating expenses fully include the Siklu acquisition impact. Research and development expenses for the first quarter on a non-GAAP basis were $8.7 million, up from $7.7 million in Q1 2023. As a percentage of revenue, our R&D expenses were 9.8% in the first quarter compared to 9.2% in the first quarter last year. Sales and marketing expenses for the first…

[Operator Instructions] Our first question will be from Alex Henderson from Needham & Company.

I hope you can hear me okay.

Yes, Alex.

Just a couple of questions very quickly on the commentary. The 100 gig system on a chip product that's still on schedule to be GA this year. Is that correct?

We intend to launch this product by the end of 2024, indeed.

Okay. Perfect. And then the second, you made a comment about the new products launched -- recently launched. The one of them was seeing significant orders. Can you give us some more granularity around which one of the products it was? And what kind of orders are you seeing? And what are the ramp of those 2 products that were -- such important products that were launched here in the current quarter? What's the ramp look like?

Yes. So, regarding the first one that we already started delivering significant quantities. It's our new all outdoor, probably the tiniest one in the industry microwave product and it gets a lot of traction, primarily in India. It basically replaces our old IP-20C that is kind of in relative advanced stages. And definitely, we see a lot of traction. And obviously, the first links were launched with the frequencies that are associated with the Indian market because of the huge demand, but we do expect to basically have this product with much more frequencies in the coming quarters and we believe it will also ramp up very nicely in the rest of the world. As to the other product we are talking about a smaller and more cost efficient E-band that is suitable very nicely to Tier 1 operators, but also to smaller ISPs. This one was already -- we already started production and delivery, but the quantities were very minimal, and we expect this product to start contributing to our business in this quarter and definitely more significance in the second part of 2024.

Can you talk a little bit about the linearity that you expect over the course of the year and give us some sense of -- I'm assuming that the June quarter is sub $100 million but up nicely from the seasonally softest quarter of the year, the March quarter. Can you talk a little bit about linearity over the quarter -- over the year?

So look, one major factor that will impact the linearity is obviously the fact that in Q2, we are starting to deliver our products and obviously, also start also starting the installation of the big contract we won with the new customer in India. And that by itself should put us in a level of revenue that is higher. Generally speaking, following Q1 booking, basically, the backlog we have enabled us to get to $100 million. The main, so to speak, 2 factors that will define whether we will be able to kind of create a more rationalized quarter-over-quarter revenues are basically 2. One, the customer demand and the pace they want us to deliver these orders. And second, our ability and capacity to manufacture the products in a timely fashion. Now in terms of manufacturing capacity, we have no issue. But yet as a very cautious company, until we receive the large orders or the initial large orders from India, we are very careful in terms of component buying and that may cause certain delays that I think that within less than a quarter we'll be able to overcome. So to summarize, in Q2, we do expect a ramp in the business or in the revenue generation. But I think that during the second half of the year, if assuming customers continue with the same, so to speak, expectations of delivery time line, we will probably be achieving beyond $100 million a quarter in this second part.

The gross margin numbers, 36.7% in the quarter, I'm assuming that you're not going to be doing that again here in the June quarter or even in the back half with the mix shifting towards India, which generally a lower margin. Is it reasonable to think that's more on the 35.5%-ish range for the next couple quarters as that -- as that kicks in? And you have start-up costs with your new products?

Alex, it's Ronen. As I said in the previous call, I think that we would be around between the 35% to 37%. On average, we will -- we opt to -- we target to reach the 36%. So, yes, something in between the 35.5% and 36% as an average is reasonable. It might go down to around 35%, but it might go up also to 37%, depending on the specific quarter, specific mixture by regions and a specific product mixture or services mixture, whether we give more software or not very much dependent on how backlog is being -- the very good backlog that we have is converted depending on the specific needs in each quarter of the customers.

Just to add on top of it, I think in the last -- in the previous call, we said that we are planning for further improvement in our gross margin on an annual basis. Last year, we ended up with a gross margin that is slightly shy of 35% non-GAAP. And as we said in the previous conference call, we are shooting and we believe that with the right, so to speak, mix, no big changes in what we expect. We are nearing -- we will be nearing the 36%, and that's our minimum goal for this year.

One last question, then I'll cede the floor and get back in queue. Can you remind us where we are on the book-to-bill in the -- as we exited '23 and what the book-to-bill look like in the first quarter?

Yes. Look, first of all, we did not specifically refer to that in the last 2 quarters because I think that on a quarterly basis, it may miss early. Last quarter and for the full year of 2023, we were with book-to-bill above 1. And also after this quarter and I think that my prepared comments were alluding to that very strongly, we had a huge book-to-bill that is hugely above 1. And I don't want to kind of create a situation where people are, maybe misled by this because, obviously, getting this amount of orders from India in advance in order to prepare us to the very big volumes of delivery is not necessarily indicating what we expect to happen each and every quarter. So all-in-all, very strong end of 2023, very strong beginning of Q1 2024. I think that the way to look at the bookings is more on a trailing 12-month approach. And definitely on a trailing 12-month period, we are way above one in terms of book-to-bill.

Our next question is from Rommel Dionisio of Aegis Capital. Rommel?

Rommel, we cannot hear you.

Doron, can you hear me okay?

Yes, I can hear you.

So you've obviously made significant progress on the private network. So I wonder, if you could just give us a little more color on that. Obviously, some significant events here over the last several months and the business prospects both in North America and Europe for that?

So I will start with, what I was saying in the previous conference call. We ended up last year with $40 million of booking in the private networks and we aspire to double this amount in 2024. This plan has not changed and we definitely see a path for getting to this level of booking. I think this quarter was characterized by a lot of good results of hard work, especially in the energy segment where we received nearly $10 million value of orders from this segment. And I think that with our unique solution plus the fact that we have a good brand of, some sort of system integrator concept. In this particular segment, we are seeing the fruits of focusing on this segment that is going through huge transformation, digital transformation across all segments. So that's definitely encouraging. On top of that, we look at the funnel and our funnel is increasing very, very nicely. And that means that we have a very strong signals that we are getting traction with our solutions, our marketing efforts that we started in much higher pace towards the end of last year, but also increased it as part of our budget. In Q1 are also showing very strong signs of traction. And therefore, I'm quite optimistic about our ability to achieve this double number -- doubling the number of booking in this year and maybe even exceeding it.

[Operator Instructions] Our next question is from Gunther Karger. Okay. So maybe we'll move along for now to Alex Henderson.

Alex, we cannot hear you. Can you check your side of the connection?

Can you hear me now?

Yes. Gunther, go ahead.

Regarding the medical industry, a specific market, there's been a rise of interest in the artificial intelligence, the diagnostic areas and such things. With regard to the short range, millimeter range systems and diagnostic trans -- data transmissions, has there been any notice of market interest in that area?

So, I would say the following. First of all, what we are seeing following the acquisition of Siklu that, by the way, is actually heading or moving forward as planned and even slightly better. There's a lot of traction for short millimeter wave, transport solutions and fixed wireless access, especially in dense areas. And that's obviously definitely encouraging because this was the purpose of the acquisition. So in this respect, we see a lot of traction and we believe that we can increase our business in this domain, definitely leveraging our position following the acquisition of Siklu. In terms of AI, I know that people are asking questions. Some of these questions are coming via e-mail. Guys, we have already AI embedded in our software and we have different use cases where AI can be used for optimization of either the network or the wireless transport piece. And with our Digital Twin, we can even expand it beyond the just the transport itself. So we are already using this kind of tools, and it's our intention to continue leverage these kind of capabilities into our software solutions and our products.

Good luck on that. It's a big growing market.

Our next question is from Alex Henderson from Needham & Company.

I think I'm unmuted right?

Yes. Now you are good.

Yes. It didn't pop-up to unmute in a timely fashion earlier. So I get it that you've had some very large orders here. I get it that the timing of that heavily skewed to the first quarter, set you up for very strong deployments over not just to the back half of this year and but also into '25. But I was wondering, given that -- those orders, is your pipeline of additional deals still healthy and/or is there enough heft in that to continue to build more order flow over the course of the remainder of the year. What does the pipeline look like?

So the pipeline looks quite healthy, and we also actually made that comment in my prepared comment. We're also encouraged by the progress we made in other regions. It was kind of the first quarter in this year and probably for a few quarters where all other regions, without any exception had the sequential growth in the booking versus the obviously previous quarter. So that's also a good sign for us. We see a healthy pipeline in most of the regions. We see a nice pipeline, as I said in the private networks and increasing and this give us the confidence, the level of confidence that we need to feel comfortable in the path and in the target we set to ourselves for 2024.

Okay. And just going back to the inventory, I think your inventory is still a little higher than normal. How do you see that feathering down over the year? And is that going to be tied to the shipments into India or is that just normal course of business? How do we think about it?

So, Alex, first of all, thank you for the question because, yes, indeed, the inventory reduced substantially this quarter. We reduced inventories from $69 million to $61 million. So it's a positive sign because it's for quite a few quarters. I think that the last time we were in this level was around 2022. And we made a lot of progress in 2023 to come to this stage, where inventory has come down. And we believe that there is more room to decrease inventory. I'm not sure about quarter-to-quarter levels, but, over the year to continue to decrease and we have a plan to continue to decrease the inventories by at least a few couples of millions. And this is associated, of course, with the fact that we built up inventories for the new products that are now being materialized and that we are now going to start to sell over this year, and then we can streamline the new products as well as coming back from the post COVID-19 building of inventories, due to the challenges that we had of sourcing of components these years.

Alex, just to add on top of Ronen's comment, the only issue of managing our inventory that is obviously a big item on our balance sheet has stepped up dramatically since we started seeing the component market rationalizing. And there's a lot, a lot of activities on the one hand, building our plans to more of adjusting time, delivery of components. And obviously, looking at some excess and working with this excess inventory very fast in the process and not waiting too long. And all of that is creating a much more meticulous handling of our inventory. So I truly believe that we will be able to continue in this trend. There's only 2 factors that you need to take into account. One is that we need also to look at the inventory as a percentage of our volume of business. So if we are ramping up and we'll go to the $400 million revenue and maybe even exceed it, we might see the inventory rationalizing as a percentage of revenue. Definitely, if the part of the revenue that is associated with our hardware product is the one that is growing significantly. And the other thing is that sometimes I'm making decisions on a quarterly basis to get equipped with some level of inventory in advance, expecting some capacity or overcoming some capacity issues that may come because of deliveries that are specific for a specific order. So these are the 2 caveats. The bottom line is, yes, we do expect to continue rationalizing our inventory and we do expect to see further better results down the road.

Yes. In that context, obviously, you've got a very large order ramping for India and then second, you've got 2 new products that are ramping now and then another 1 that's slated to launch late in the year. Should we be looking at some start-up costs associated with those or is that embedded in, in your thinking at this point? And what size of a cost is that will eventually fall out as those products hit the normalized production level?

So these costs are already embedded in our projections. We took them into account. Usually, we try to rationalize these costs and to make these costs happen gradually so they don't have a big impact on a specific quarter. If that happens, obviously, we're going to disclose this kind of situation but we don't expect that. So eventually, when we are talking about our gross margins for the rest of the year, we have taken into account the fact that we launched the 2 new products. I don't think that the new 100 gigabit event will have an impact on this year. But as for the other products, it's taken into account and I do expect our gross margins from these products to improve almost by the quarter, as we're able to improve our performance in terms of manufacturing and BOM cost.

Now what I was trying to calibrate was the -- to what extent that abnormally large amount of startup costs in 2024, would then fall out in 2025 as the -- as these products are normalized and whether that would then imply some further upside in the gross margin in the out year. I know you don't want to give guidance for '25, but conceptually, is that a logical conclusion?

Look, the startup cost that you would see are actually categorized into 2. One is our investment in CapEx to build the testing equipment or to enhance the testing equipment to fit the new products, and that you will see in some investment in CapEx. But generally speaking, I don't think that investment in CapEx is going to be that different from previous years. And the other set, of course, that are actually going to the expenses immediately. I would not give them more than, I don't know, 0.5% of the gross margin.

Our next question is from Jeff Rosenberg from Rail-Splitter Capital. Jeff, we can't hear you.

I think you guys muted me and then unmuted me. Sorry. Can you hear me now?

Yes, Jeff.

I just wanted to ask if you could tell us what the contribution was from Siklu in the first quarter?

Look, we do not include and we don't want to separate the Siklu contribution for a very simple reason. This is a tiny transaction and the integration is so fast and so to speak deep that it's almost becoming impossible to separate the numbers. Yet just in a quality fashion, I can tell you that in the first quarter, the contribution to the gross margin of Siklu was even slightly higher than our expectation. And in terms of the business and the booking, it was also as strong as we were expecting. And I'll just remind you that our projection for 2024 was that Siklu will contribute from their specific products between $25 million to $29 million in 2024. I think that we are on a path to achieve it. And if all stars align, maybe in the second part of the year, we'll be able even to exceed this number.

Great. And the reason I was asking was just about looking at the year-over-year or even sequential growth because I think you got some contribution from Siklu in Q4. The growth looked a little slower, but I just I know it's uneven and seasonality and so maybe the comparison against last year was difficult. So maybe just to kind of talk about the just overall strength in terms of revenue in the first quarter versus obviously very good bookings and building visibility for the year?

So Jeff, if you're willing to sign an NDA and join our finance team next quarter, I would love to have you on board because you hit the nail on the head. There were a few moving factors that we thought that eventually if we start, we try to explain them, we just get everyone confused. First of all, usually Q1 is weaker and last year was a bit different for us to the good side primarily because of some delays in delivery of some of the products that were supposed to come or to be delivered in Q4 of 2022. So starting to put all these ingredients moving up and down and trying to give a more rationalized analysis of the growth, we thought that it will just confuse anyone. I think that the most important thing, especially after Alex comment about, okay, how rationalized and aligned the revenue growth between quarters that was indicating that we may see some fluctuations. So, I would not be impressed by the percentage of the Q1 versus Q1 in 2023 in terms of projecting how the full year of 2024 is going to look like.

I would add that the most important thing that we gave guidance for this year and the guidance was for revenues of between $385 million to $405 million. And we still expect to reach this guidance. And as Doron mentioned in the prepared comments, we have better visibility due to the higher volume of bookings. So we are on target at this stage.

Thank you. There are no further questions. So please proceed.

So, as I said, this was an encouraging quarter and a solid start to the year for Ceragon. We're executing against our growth strategy and capturing market share. We believe that we are well positioned to achieve self-sustaining cash flows as we execute our growth strategy. I look forward to updating you further on our next quarterly call. Have a good day everyone.